cell-penetrating modified mAbs (Sorrento/LA Cell)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namecell-penetrating modified mAbs (Sorrento/LA Cell)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionMyc proto-oncogene protein modulatorsForkhead box protein P3 modulatorsSignal transducer and activator of transcription 3 modulators +[4] 
TargetsMyc proto-oncogene proteinSignal transducer and activator of transcription 3Forkhead box protein P3 +[4] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSorrento Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLa Cell IncSorrento Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A